Table 1.
Experiment | Design | Samples | Laboratory analysis1 | Statistical analysis |
---|---|---|---|---|
1. Delayed processing of whole blood | Blood tubes stored at 32°C for 1, 2, and 3 d prior to processing and freezing at −70°C; reference: serum from promptly processed whole blood frozen at −70°C | Whole blood from 21 volunteer blood donors from CDC | 1 replicate/condition batch analyzed by HPLC-MS/MS | 1-way (time) ANOVA |
2. Delayed freezing of serum | Serum stored at 11°C for 2, 7, 10, and 14 d prior to freezing at −70°C; reference: serum from promptly processed whole blood frozen at −70°C | Serum from 21 volunteer blood donors from CDC | 1 replicate/condition batch analyzed by HPLC-MS/MS | 1-way (time) ANOVA |
3. Short-term exposure of serum to elevated temperatures | Serum stored at 22°C and 37°C for 2, 4, 6, and 24 h prior to freezing at −70°C; reference: serum stored at −70°C | Low, medium, and high serum QC pools | 4 replicates/condition batch analyzed by HPLC-MS/MS | 2-way (time, pool level) ANOVA |
4. Repeated freeze/thawing of serum (closed vials) | Serum exposed to up to 3 freeze/thawing cycles (2 h/cycle at room temperature in closed vials); reference: serum stored at −70°C | Low, medium, and high serum QC pools | 4 replicates/condition batch analyzed by HPLC-MS/MS | 2-way (time, pool level) ANOVA |
5. Repeated freeze/thawing of serum (open vials) | Serum from same vial exposed to up to 4 analyses (2 h/analysis at room temperature in open vials); reference: 1st analysis | 30 pooled samples from serum from a large CDC study | 1 replicate/condition batch analyzed by HPLC-MS/MS | 1-way (time) repeated measures ANOVA |
6. Long-term frozen storage of serum | Serum stored at −20°C for 3, 6, 9, and 12 mo prior to freezing at −70°C; reference: serum stored at −70°C | Low, medium, and high serum QC pools | 6 replicates/condition batch analyzed by HPLC-MS/MS | 2-way (time, pool level) ANOVA |
7. Long-term refrigerated storage of serum | Serum stored at 5°C for 6 and 12 mo prior to freezing at −70°C; reference: serum stored at −70°C | Low, medium, and high serum QC pools | 6 replicates/condition batch analyzed by HPLC-MS/MS | 2-way (time, pool level) ANOVA |
HPLC-MS/MS method used for experiments 6 and 7 did not separate the two isobaric compounds MeFox (pyrazino-s-triazine derivative of 4α-hydroxy-5-methyltetrahydrofolate) and 5-formyltetrahydrofolate